PT Phapros Tbk (IDX:PEHA)

PT Phapros Tbk Revenue

PT Phapros Tbk had revenue of 303.72B IDR in the quarter ending September 30, 2026, with 34.78% growth. This brings the company's total for the last twelve months to 1.04T, up 21.93% year-over-year. In the year 2025, PT Phapros Tbk had annual revenue of 940.88B with 26.34% growth. That makes PT Phapros Tbk the 26,914th largest company in the world by revenue and 438th in Indonesia.

• Revenue (ttm): 1.04T
• Revenue Growth: +21.93%
• P/S Ratio: 0.21
• Revenue / Employee: 831.77M
• Employees: 1,255
• Market Cap: 225.12B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• OGB (Generic Drugs Bearing) 485.21B 51.6%
• Ethical 246.89B 26.2%
• OTC (Over The Counter) 197.78B 21.0%
• Toll-In 11.00B 1.2%

Fiscal year ended Dec 31, 2025 See the full PT Phapros Tbk breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	940.88B	196.19B	26.34%
Dec 31, 2024	744.69B	-258.88B	-25.80%
Dec 31, 2023	1.00T	-164.90B	-14.11%
Dec 31, 2022	1.17T	117.03B	11.13%
Dec 31, 2021	1.05T	70.89B	7.23%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error